Skip to main content
. 2015 Oct 6;9:388. doi: 10.3389/fncel.2015.00388

Figure 5.

Figure 5

Effects of fluoxetine on gene expression of 5-HT2B receptor and behavior changes of anhedonia mice. After either 7 days or 14 days (7 days after the end of MPTP treatment) of MPTP treatment, mice with anhedonia were daily injected intraperitoneally with fluoxetine (10 mg/kg/d dissolved in 0.9% NaCl) or saline for 14 days. (A) mRNA expression of 5-HT2B receptor was measured by RT-PCR. A representative experiment showing mRNA for 5-HT2B receptor and for TBP, as a housekeeping gene. The size of PCR product of 5-HT2B receptor is 370 bp, and that of TBP 236 bp. Similar results were obtained in three independent experiments. Average mRNA expression was quantified as ratios between 5-HT2B receptor and the housekeeping TBP gene. Ratios between 5-HT2B receptor and TBP in control group were designated a value of one. SEM values are indicated by vertical bars. *Indicates statistically significant (p < 0.05) difference from other groups. (B) Protein level measured by immunoblotting of 5-HT2B receptor (55 kDa). Immunoblots from representative experiments. Bands of 55 and 42 kDa represent 5-HT2B receptor and β-actin, respectively. Similar results were obtained in three independent experiments. Average protein level was quantified as ratios between 5-HT2BR and β-actin. Ratios between 5-HT2B receptor and β-actin in control group were designated a value of one. SEM values are indicated by vertical bars. *Indicates statistically significant (p < 0.05) difference from other groups. (C) Percentage of sucrose preference. Values were expressed as the mean ± SEM (7 days, n = 5; 14 days, saline: n = 6, MPTP: n = 6, flu: n = 5, MPTP plus flu: n = 6). *Indicates statistically significant (p < 0.05) difference from other groups at the same treatment period. (D) Forced-swimming test. The values of immobility time are expressed as the mean ± SEM (7 days, n = 5; 14 days, saline: n = 6, MPTP: n = 6, flu: n = 5, MPTP plus flu: n = 6). *Indicates statistically significant (p < 0.05) difference from other groups at the same treatment period.